B

Bolt Biotherapeutics
D

BOLT

0.66000
USD
0.02
(2.56%)
Market Closed
Volume
73
EPS
0
Div Yield
0
P/E
-0
Market Cap
25,254,796
OverviewSignalsIdeasNews
Related Instruments
    E
    ENJ
    -0.100
    (-0.47%)
    21.300 USD
    F
    FET
    -1.030
    (-5.59%)
    17.400 USD
    S
    SAND
    -0.11500
    (-2.00%)
    5.64000 USD
    S
    SLP
    -0.890
    (-2.18%)
    39.990 USD
    More
News

Title: Bolt Biotherapeutics

Sector: Healthcare
Industry: Biotechnology
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on our deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.